B.‐M. Svahn

740 total citations
13 papers, 526 citations indexed

About

B.‐M. Svahn is a scholar working on Hematology, Oncology and Infectious Diseases. According to data from OpenAlex, B.‐M. Svahn has authored 13 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in B.‐M. Svahn's work include Hematopoietic Stem Cell Transplantation (8 papers), Neutropenia and Cancer Infections (3 papers) and Acute Myeloid Leukemia Research (2 papers). B.‐M. Svahn is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Neutropenia and Cancer Infections (3 papers) and Acute Myeloid Leukemia Research (2 papers). B.‐M. Svahn collaborates with scholars based in Sweden, United States and Italy. B.‐M. Svahn's co-authors include Mats Remberger, Olle Ringdén, Christina Löfgren, P Hentschke, Jacek Winiarski, Per Ljungman, J Aschan, Jonas Mattsson, Stefan Carlens and Sven Klaesson and has published in prestigious journals such as Transplantation, Journal of Internal Medicine and Acta Paediatrica.

In The Last Decade

B.‐M. Svahn

13 papers receiving 518 citations

Peers

B.‐M. Svahn
B.‐M. Svahn
Citations per year, relative to B.‐M. Svahn B.‐M. Svahn (= 1×) peers Sophie Servais

Countries citing papers authored by B.‐M. Svahn

Since Specialization
Citations

This map shows the geographic impact of B.‐M. Svahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.‐M. Svahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.‐M. Svahn more than expected).

Fields of papers citing papers by B.‐M. Svahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.‐M. Svahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.‐M. Svahn. The network helps show where B.‐M. Svahn may publish in the future.

Co-authorship network of co-authors of B.‐M. Svahn

This figure shows the co-authorship network connecting the top 25 collaborators of B.‐M. Svahn. A scholar is included among the top collaborators of B.‐M. Svahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.‐M. Svahn. B.‐M. Svahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bonde, Lars Ole, et al.. (2016). Music therapy can lower the heart rates of severely sick children. Acta Paediatrica. 105(10). 1225–1230. 32 indexed citations
2.
Ambati, Aditya, Thomas Poiret, B.‐M. Svahn, et al.. (2015). Increased β‐haemolytic group A streptococcal M6 serotype and streptodornase B‐specific cellular immune responses in Swedish narcolepsy cases. Journal of Internal Medicine. 278(3). 264–276. 23 indexed citations
3.
Svahn, B.‐M., et al.. (2012). Increased Costs After Allogeneic Haematopoietic SCT Are Associated with Major Complications and Re-Transplantation. Biology of Blood and Marrow Transplantation. 18(2). S339–S339. 1 indexed citations
4.
Mattsson, Jonas, et al.. (2012). Ten Years Experience of Home-Care During the Neutropenic Phase After Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 18(2). S359–S359. 1 indexed citations
5.
Giraud, G, Peter Priftakis, Gordana Bogdanović, et al.. (2008). BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts. Bone Marrow Transplantation. 41(8). 737–742. 56 indexed citations
6.
Svahn, B.‐M., et al.. (2006). Costs of allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 12(2). 25–25. 1 indexed citations
7.
Mattsson, Jonas, Mats Remberger, B.‐M. Svahn, et al.. (2006). Allogeneic hematopoietic stem cell transplantation for inherited disorders: Experience in a single-center. Biology of Blood and Marrow Transplantation. 12(2). 126–126. 4 indexed citations
8.
Svahn, B.‐M., Olle Ringdén, & Mats Remberger. (2005). Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplantation. 36(6). 511–516. 35 indexed citations
9.
Svahn, B.‐M., et al.. (2004). Is it safe to treat allogeneic stem cell transplanted recipients at home during the pancytopenic phase?. La Presse Médicale. 33(7). 474–478. 7 indexed citations
10.
Remberger, Mats, B.‐M. Svahn, P Hentschke, Christina Löfgren, & Olle Ringdén. (1999). Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation. Bone Marrow Transplantation. 24(8). 823–830. 120 indexed citations
11.
Carlens, Stefan, Olle Ringdén, Mats Remberger, et al.. (1998). Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplantation. 22(8). 755–761. 157 indexed citations
12.
n, Olle Ringd, Mats Remberger, Stefan Carlens, et al.. (1998). LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-, HLA-B-, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES1. Transplantation. 66(5). 620–625. 62 indexed citations
13.
Ringdén, Olle, et al.. (1996). Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients. Mycoses. 39(5-6). 185–193. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026